Creative Bio-Peptides Competitors and Similar CompaniesClear all
Upstream Bio's competitors and similar companies include AbClon.
 Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ||
Founding Date | Founding Date 2021 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations KR HQ |
Employees | Employees 38 | Employees N/A |
Financial | ||
Revenue (est.) | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) ₩2.3b (FY, 2024) |
Cost of goods | Cost of goods $23m (FY, 2025) | Cost of goods (₩74.1m) (FY, 2024) |
Gross profit | Gross profit ($20.2m) (FY, 2025) | Gross profit ₩2.4b (FY, 2024) |
Net income | Net income ($143.4m) (FY, 2025) | Net income (₩16.3b) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
AbClon
HQ
KR
AbClon (앱클론(주)) is a developer, manufacturer, and distributor of antibody drugs.
View company